garetosmab-grts
garetosmab-grts is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Pasatru. Available dosage form: injection, solution, concentrate.
Drug details
- Generic Name
- garetosmab-grts
- Brand Names
- Pasatru
- Application Number
- BLA761508
- Sponsor
- Regeneron Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- GARETOSMAB
Indications and Usage
1 INDICATIONS AND USAGE PASATRU is indicated to reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP). PASATRU is an activin signaling inhibitor indicated to reduce formation of new heterotopic ossification (HO) lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva (FOP). ( 1 )